Product Information
GLIPIZIDE-METFORMIN 2.5-500 MG is a generic product labeled by Chartwell RX LLC, priced at $0.2334 per EA under NDC 62135073260. Its NADAC has been published 120 times since Mar 13, 2024.
Strength
2.5; 500 mg/1; mg/1
Manufacturer
Chartwell RX LLCNDC
62135073260
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
GLIPIZIDE; METFORMIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA078728On Market Since
6/29/2010
Pharmacological Classes
Price Statistics
The NADAC for GLIPIZIDE-METFORMIN 2.5-500 MG has been published 120 times since Mar 13, 2024, and over the history we have for it it has declined 22.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2334 per EA |
|---|---|
| All-time high | $0.3512 (Apr 10, 2024) |
| All-time low | $0.2207 (Apr 17, 2024) |
| 52-week high | $0.3088 |
| 52-week low | $0.2223 |
| Median price | $0.2491 |
| Average price | $0.2600 |
| Largest weekly change | -37.1% (Apr 17, 2024) |
| Weeks tracked | 120 |
| Tracking since | Mar 13, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Glipizide and metformin hcl market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of GLIPIZIDE-METFORMIN 2.5-500 MG?
The current National Average Drug Acquisition Cost (NADAC) for GLIPIZIDE-METFORMIN 2.5-500 MG, manufactured by Chartwell RX LLC, is $0.2334 per EA (NDC 62135073260), effective Jun 24, 2026.
How has the price of GLIPIZIDE-METFORMIN 2.5-500 MG changed over time?
Over the history we have for it, the NADAC for GLIPIZIDE-METFORMIN 2.5-500 MG has declined 22.5%. It has been tracked across 120 weekly CMS publications since Mar 13, 2024.
What are the highest and lowest recorded NADAC prices for GLIPIZIDE-METFORMIN 2.5-500 MG?
Since Mar 13, 2024, the NADAC for GLIPIZIDE-METFORMIN 2.5-500 MG has ranged from a low of $0.2207 (Apr 17, 2024) to a high of $0.3512 (Apr 10, 2024), with a median of $0.2491 per EA.
Are there cheaper alternatives to GLIPIZIDE-METFORMIN 2.5-500 MG?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of GLIPIZIDE-METFORMIN 2.5-500 MG, so no direct lower-cost alternative is listed.
Who manufactures GLIPIZIDE-METFORMIN 2.5-500 MG?
GLIPIZIDE-METFORMIN 2.5-500 MG (NDC 62135073260) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification